| GTO ID | GTC0717 |
| Trial ID | ACTRN12622001514796 |
| Disease | Glioblastoma |
| Altered gene | GD2 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | GD2 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | KARPOS - A Phase 1, Single-Centre, Non-randomised, Open-labelled, Escalating Dose Study of Autologous GD2-Specific Chimeric Antigen Receptor-expressing Peripheral Blood T cells in Patients with Recurrent GD2-positive Glioblastoma Multiforme |
| Year | 2022 |
| Country | Australia |
| Company sponsor | Royal Adelaide Hospital |
| Cohort 1 | |||||||||||||
|
|||||||||||||